RecruitingPhase 3NCT05597917

tTF-NGR Randomized Study - STS

Studying OBSOLETE: Pleomorphic undifferentiated sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universität Münster
Principal Investigator
Christoph Schliemann, Prof. Dr.
University Hospital Muenster (Department of Medicine A), Germany
Intervention
Trabectedin(drug)
Enrollment
126 enrolled
Eligibility
18-75 years · All sexes
Timeline
20212026

Study locations (9)

Collaborators

Anturec Pharmaceuticals GmbH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05597917 on ClinicalTrials.gov

Other trials for OBSOLETE: Pleomorphic undifferentiated sarcoma

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Pleomorphic undifferentiated sarcoma

← Back to all trials